Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 7/20 | 0.57 |
| ▸ | RET | P07949 | 2/20 | 0.55 |
| ▸ | HIPK4 | Q8NE63 | 2/20 | 0.55 |
| ▸ | PLK4 | O00444 | 1/20 | 0.55 |
| ▸ | AURKA | O14965 | 1/20 | 0.55 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.55 |
| ▸ | JAK2 | O60674 | 1/20 | 0.55 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.55 |
| ▸ | ABL1 | P00519 | 1/20 | 0.55 |
| ▸ | LCK | P06239 | 1/20 | 0.55 |
| ▸ | FYN | P06241 | 1/20 | 0.55 |
| ▸ | LYN | P07948 | 1/20 | 0.55 |
| ▸ | ROS1 | P08922 | 1/20 | 0.55 |
| ▸ | SRC | P12931 | 1/20 | 0.55 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.55 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.55 |
| ▸ | TYK2 | P29597 | 1/20 | 0.55 |
| ▸ | AXL | P30530 | 1/20 | 0.55 |
| ▸ | FRK | P42685 | 1/20 | 0.55 |
| ▸ | SYK | P43405 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14527325 | 0.89 | NPC1 (0.58) | KDRRETHIPK4PLK4AURKA | |
| SCHEMBL18681347 | 0.86 | BRAF (0.70) | KDRRETHIPK4PLK4AURKA | |
| SCHEMBL167783 | 0.85 | KDR (0.58) | KDRRETHIPK4PLK4AURKA | |
| SCHEMBL14527286 | 0.85 | KDR (0.60) | KDRRETHIPK4PLK4AURKA | |
| SCHEMBL19888709 | 0.84 | KDR (0.76) | KDRRETHIPK4PLK4AURKA | |
| SCHEMBL3991905 | 0.84 | KDR (0.57) | KDRRETHIPK4PLK4AURKA | |
| SCHEMBL177723 | 0.84 | KDR (0.57) | KDRRETHIPK4PLK4AURKA | |
| SCHEMBL14527329 | 0.83 | KDR (0.56) | KDRRETHIPK4PLK4AURKA | |
| SCHEMBL26922854 | 0.83 | KDR (0.63) | KDRRETHIPK4PLK4AURKA | |
| SCHEMBL29834816 | 0.83 | KDR (0.63) | KDRRETHIPK4PLK4AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112851577-A | Preparation method of regorafenib | 齐鲁制药有限公司 | 2021-05-28 | — | — | CN | disclosed |
| US-8637553-B2 | Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions | BAYER HEALTHCARE LLC (US) | 2014-01-28 | — | — | US | disclosed |
| US-20130131122-A1 | Fluro substituted Omega-Carboxyaryl Diphenyl Urea for the Treatment and Prevention of Diseases and Conditions | BAYER HEALTHCARE LLC (US) | 2013-05-23 | — | — | US | disclosed |
| EP-1663978-B1 | FLUORO SUBSTITUTED OMEGA-CARBOXYARYL DIPHENYL UREA FOR THE TREATMENT AND PREVENTION OF DISEASES AND CONDITIONS | BAYER PHARMACEUTICALS CORP (US) | 2007-11-28 | — | — | EP | disclosed |
| EP-1663978-A2 | FLUORO SUBSTITUTED OMEGA-CARBOXYARYL DIPHENYL UREA FOR THE TREATMENT AND PREVENTION OF DISEASES AND CONDITIONS | Bayer Pharmaceuticals Corporation (US) | 2006-06-07 | — | — | EP | disclosed |
| US-20050038080-A1 | Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions | BAYER HEALTHCARE LLC | 2005-02-17 | — | — | US | disclosed |
| WO-2005009961-A2 | FLUORO SUBSTITUTED OMEGA-CARBOXYARYL DIPHENYL UREA FOR THE TREATMENT AND PREVENTION OF DISEASES AND CONDITIONS | BAYER PHARMACEUTICALS CORPORATION (US) | 2005-02-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130131122-A1 | Fluro substituted Omega-Carboxyaryl Diphenyl Urea for the Treatment and Prevention of Diseases and Conditions | FLT1, FLT4, PDGFRA | KDR 8/4885RET 139/4885HIPK4 4013/4885 |
| US-20050038080-A1 | Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions | FLT4, FLT1, PDGFRB | KDR 5/4885RET 181/4885HIPK4 3651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.